Epilepsy Pathway Innovation in Africa
Epilepsy affects over 50 million people across the world. 80% of these people live in low to middle income countries. There is a very high rate of epilepsy in Africa, where misunderstanding and stigma lead to limited diagnoses and treatment.
Epilepsy Pathway Innovation in Africa (EPINA) is a research team based in Oxford that has partnered with leading institutions in Kenya, Ghana and Tanzania. Working in these countries, EPINA aims to:
- better understand the impact of stigma on people with epilepsy
- improve epilepsy knowledge to improve help-seeking and treatment
- develop an app to help healthcare workers to diagnose epilepsy
- develop portable electroencephalograms to diagnose epilepsy in rural settings
- improve medication adherence through text messaging.
EPINA could dramatically change the lives of people with epilepsy in sub Saharan Africa. If successful, we will use our knowledge to ensure that similar work is carried out across other low and middle-income countries.
Visit the EPInA website here: https://epina.web.ox.ac.uk
Impact of the COVID-19 pandemic on people with epilepsy: Findings from the Brazilian arm of the COV-E study
Andraus M. et al, (2021), Epilepsy and Behavior, 123
Dystrophin involvement in peripheral circadian SRF signalling
Betts CA. et al, (2021), Life Science Alliance, 4, e202101014 - e202101014
Dim light in the evening causes coordinated realignment of circadian rhythms, sleep, and short-term memory.
Tam SKE. et al, (2021), Proc Natl Acad Sci U S A, 118
The Clinical Use of Vernier Acuity: Resolution of the Visual Cortex Is More Than Meets the Eye
Hu M. et al, (2021), Frontiers in Neuroscience